首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
【24h】

Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.

机译:针对狗-白细胞抗原相同的混合造血犬嵌合体中肾脏靶标的过继免疫疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND Stable mixed-donor-host-hematopoietic chimerism can serve as a platform for adoptive immunotherapy. Infusions of donor lymphocytes (DLI) sensitized against hematopoietic cells converted mixed hematopoietic into full-donor chimerism in dog-leukocyte antigen (DLA)-identical littermates. Whether sensitization against tissue of solid organs leads to organ-specific immunity that can be transferred by DLI was unknown and was investigated in these experiments using the kidney as target.METHODS DLA-identical recipients with established stable mixed-donor-host-hematopoietic chimerism were used. In five pairs, hematopoietic stem-cell transplant (HSCT) donors were sensitized by kidney transplantation from the respective chimeras. In a second group, five HSCT donors received vaccinations that were generated from kidney cells of the respective mixed chimeras. Twenty-eight days after sensitization, DLI were administered to the mixed-hematopoietic chimeras.RESULTS All HSCT donors rejected their kidney grafts from their mixed-chimeric recipients within 22 to 45 days. DLI caused no sustained graft-versus-kidney effects in the mixed-chimeric recipients. However, DLI donors sensitized by kidney transplantation converted 4 of 5 mixed chimeras into virtually complete (>95%) donor-type chimeras, compared with 1 of 5 mixed chimeras given DLI by vaccination from sensitized donors.CONCLUSION Although DLA-identical kidney grafts from mixed-hematopoietic chimeras were readily rejected by their HSCT donors, subsequent transfusions of sensitized-donor lymphocytes into mixed chimeras converted mixed to all-donor chimerism but failed to induce graft-versus-kidney effects. Vaccination strategies in lieu of kidney grafts failed to convert mixed chimerism.
机译:背景技术稳定的混合供体-宿主造血嵌合体可以用作过继免疫疗法的平台。对造血细胞敏感的供体淋巴细胞(DLI)的输注将混合的造血转化为在狗白细胞抗原(DLA)相同的同窝仔中的全供体嵌合。尚不清楚对实体器官的敏化是否会导致DLI可以转移的器官特异性免疫力,并且在这些实验中以肾脏为靶点进行了研究。方法与DLA相同的接受者已经建立了稳定的混合供体-宿主-造血嵌合体。用过的。在五对中,通过来自各个嵌合体的肾脏移植使造血干细胞移植(HSCT)供体敏化。在第二组中,五名HSCT供体接受了各自混合嵌合体肾脏细胞产生的疫苗接种。致敏后28天,将DLI用于混合造血嵌合体。结果所有HSCT供体在22至45天内拒绝了其混合嵌合体接受者的肾移植。 DLI在混合嵌合受体中未引起持续的移植物抗肾作用。然而,通过肾脏移植致敏的DLI供体将5种混合嵌合体中的4种转化为几乎完全的(> 95%)供体型嵌合体,相比之下,通过从致敏的供体中接种DLI的5种混合嵌合体中就有1种。混合造血嵌合体很容易被其HSCT供体排斥,随后将致敏的供体淋巴细胞输注到混合的嵌合体中,转化成混合的全供体嵌合体,但未能引起移植物抗肾作用。代替肾脏移植物的疫苗接种策略未能转化为混合嵌合体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号